The Autoinjectors Market is gaining significant momentum as healthcare systems worldwide shift toward patient-centric drug delivery solutions that improve safety, convenience, and treatment adherence. Valued at USD 1,102.32 million in 2024, the market is projected to expand at a robust CAGR of 13.90% from 2025 to 2032. This growth is fueled by the rising prevalence of chronic diseases,...
The pharmaceutical landscape is entering a phase of unprecedented focus on immune-mediated diseases, with research teams racing to develop treatments for conditions ranging from autoimmune disorders to chronic inflammatory diseases. The key to this progress is not just advanced molecular tools—it is also the strategic use of robust preclinical disease models that faithfully recapitulate...
[Hyderabad, March 26th, 2025]– – The Rheumatoid Arthritis (RA) drugs market is experiencing robust growth, driven by the rising prevalence of RA, the expansion of biologic therapies, and improved patient access to targeted immune-modulating treatments. Valued at USD XX billion in 2019, the market reached USD XX billion in 2023 and is projected to expand at a CAGR of XX% from 2024 to...